Back to
PINEBRIDGE INVESTMENTS LLC
HALO
3 quarters
Position history for
PINEBRIDGE INVESTMENTS LLC's holdings in HALOZYME THERAPEUTICS INC
No. PineBridge Investments exited its HALO (Halozyme Therapeutics) position in Q2 2026. Its Q1 2026 13F listed 11,355 shares worth $733,874. PineBridge Investments already held HALO in its Q4 2025 13F, the earliest on record, and held it in 2 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$893,946
Total Shares Change
-13,283
Quarter-by-Quarter History